文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

对一种新型的远程提供给患有阿片类药物使用障碍的住院患者的强化门诊项目进行试点测试。

Pilot testing a novel remotely delivered intensive outpatient program for hospitalized patients with opioid use disorder.

作者信息

Szpak Veronica, Carc Andrea Velez, Prostko Sara, Rosenblum Naomi, Maurer Rie, Aguiar Lyndon J, Weiss Roger D, Suzuki Joji

机构信息

Department of Psychiatry, Brigham and Women's Hospital, 60 Fenwood Rd, Boston, MA, 02115, USA.

Harvard Catalyst, Boston,, MA, USA.

出版信息

Addict Sci Clin Pract. 2025 Aug 1;20(1):61. doi: 10.1186/s13722-025-00589-4.


DOI:10.1186/s13722-025-00589-4
PMID:40751223
Abstract

BACKGROUND: Individuals with opioid use disorder (OUD) are frequently hospitalized for injection-related medical complications, yet they often receive inadequate treatment for the OUD itself. We previously conducted a qualitative study to adapt an existing remotely delivered intensive outpatient program (IOP) specifically for hospitalized patients with OUD. We then conducted a pilot feasibility and acceptability study to assess the program. METHODS: The 4-week IOP consisted of asynchronous video content and in-person peer support. The primary outcomes were the feasibility of recruitment, acceptability of the treatment as assessed by the completion of videos, and engagement with the peer recovery coach. Secondary outcomes included OUD treatment retention. RESULTS: Of the 12 participants, the mean age was 40.9 years, 58.3% were female, and 58.3% had an injection-related serious infection. Results demonstrated potentially acceptable recruitment feasibility (70.6%, 95% CI [48.9-92.3]), but the median percentage of video completion was only 2% (range: 0-16%) and the median percentage of engagement with recovery coach was 31.8% (range: 16.7-66.7%). All participants received medications for OUD (MOUD) during the hospital stay (methadone 83%, buprenorphine 17%), and 33.3% remained retained in MOUD treatment at 28 days. CONCLUSIONS: Hospitalized patients with OUD desired additional support through an IOP along with MOUD. While recruitment feasibility was acceptable, the overall program was not. Future research should explore IOP content that is more personalized and engaging while also including peer support.

摘要

背景:患有阿片类物质使用障碍(OUD)的个体经常因注射相关的医疗并发症而住院,但他们对OUD本身的治疗往往不足。我们之前进行了一项定性研究,以改编现有的远程提供的强化门诊项目(IOP),专门针对住院的OUD患者。然后我们进行了一项试点可行性和可接受性研究来评估该项目。 方法:为期4周的IOP包括异步视频内容和面对面的同伴支持。主要结局是招募的可行性、通过视频完成情况评估的治疗可接受性以及与同伴康复教练的互动。次要结局包括OUD治疗的持续性。 结果:12名参与者的平均年龄为40.9岁,58.3%为女性,58.3%患有与注射相关的严重感染。结果显示招募可行性可能是可接受的(70.6%,95%CI[48.9 - 92.3]),但视频完成的中位数百分比仅为2%(范围:0 - 16%),与康复教练互动的中位数百分比为31.8%(范围:16.7 - 66.7%)。所有参与者在住院期间都接受了阿片类物质使用障碍药物治疗(MOUD)(美沙酮83%,丁丙诺啡17%),28天时33.3%仍在接受MOUD治疗。 结论:住院的OUD患者希望通过IOP以及MOUD获得额外支持。虽然招募可行性是可接受的,但整个项目并非如此。未来的研究应探索更个性化、更具吸引力且包含同伴支持的IOP内容。

相似文献

[1]
Pilot testing a novel remotely delivered intensive outpatient program for hospitalized patients with opioid use disorder.

Addict Sci Clin Pract. 2025-8-1

[2]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[3]
Opioid agonist therapy for opioid use disorder in primary versus specialty care.

Cochrane Database Syst Rev. 2025-9-8

[4]
Feasibility of Web-Based Single-Session Empowered Relief in Patients With Chronic Pain Taking Methadone or Buprenorphine: Protocol for a Single-Arm Trial.

JMIR Res Protoc. 2024-6-6

[5]
Initiating Injectable Buprenorphine in People Hospitalized With Infections: A Randomized Clinical Trial.

JAMA Netw Open. 2025-5-1

[6]
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder.

Addict Sci Clin Pract. 2024-12-2

[7]
The Support Hospital Opioid Use Disorder Treatment (SHOUT) Texas program implementation strategy for expanding treatment for hospitalized adults with opioid use disorder.

J Subst Use Addict Treat. 2025-1

[8]
Relationship of hub and treatment characteristics with client outcomes in the initial Washington State hub and spoke cohort.

J Subst Use Addict Treat. 2025-1

[9]
Mindful moms: acceptability and impact of co-designed and digitally delivered video meditations for pregnant and parenting women with opioid use disorder.

Ann Med. 2025-12

[10]
Health Services Usage in Patients Receiving Buprenorphine for Opioid Use Disorder or Long-Term Opioid Therapy for Chronic Pain: Retrospective Cohort Study.

JMIR Form Res. 2025-6-19

本文引用的文献

[1]
Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts.

JAMA Netw Open. 2024-7-1

[2]
Developing a remotely delivered intensive outpatient program adapted for hospitalized patients with opioid use disorder: A qualitative study.

Addict Behav Rep. 2024-4-19

[3]
Digitally Assisted Peer Recovery Coach to Facilitate Linkage to Outpatient Treatment Following Inpatient Alcohol Withdrawal Treatment: Proof-of-Concept Pilot Study.

JMIR Form Res. 2023-7-5

[4]
Rewarding recovery: the time is now for contingency management for opioid use disorder.

Ann Med. 2022-12

[5]
Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS.

Drug Alcohol Depend. 2021-12-1

[6]
Peer recovery coaches in general medical settings: Changes in utilization, treatment engagement, and opioid use.

J Subst Abuse Treat. 2021-3

[7]
Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018.

PLoS One. 2020

[8]
Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis.

JAMA Netw Open. 2020-10-1

[9]
Disparities in United States hospitalizations for serious infections in patients with and without opioid use disorder: A nationwide observational study.

PLoS Med. 2020-8-7

[10]
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.

JAMA Netw Open. 2020-2-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索